Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1450, 2004-01, pp. : 10-10
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Levocetirizine improves HRQOL in children with PAR
Inpharma, Vol. 1, Iss. 1502, 2005-01 ,pp. :
Levocetirizine improves HRQOL in children with PAR
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 485, 2005-01 ,pp. :
Olanzapine and risperidone on a par in schizophrenia
Inpharma, Vol. 1, Iss. 1240, 2000-01 ,pp. :
Olanzapine and risperidone on a par in schizophrenia
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 265, 2000-01 ,pp. :
Role of PAR2 in pain and inflammation
Trends in Pharmacological Sciences, Vol. 23, Iss. 4, 2002-04 ,pp. :